Bioharvest Sciences Inc (BHST) has a current Price-to-Book (P/B) ratio of 13.21. Compared to its 3-year average P/B ratio of -14.19, the current P/B ratio is approximately -193.13% higher. Relative to its 5-year average P/B ratio of -14.19, the current P/B ratio is about -193.13% higher. Bioharvest Sciences Inc (BHST) has a Forward Free Cash Flow (FCF) yield of approximately -8.01%. Compared to its 3-year average FCF yield of -7.83%, the current FCF yield is approximately 2.36% lower. Relative to its 5-year average FCF yield of -7.83%, the current FCF yield is about 2.36% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for BHST competitors is 0.64, providing a benchmark for relative valuation. Bioharvest Sciences Inc Corp (BHST.O) exhibits a P/S ratio of 2.76, which is 329.52% above the industry average. Given its robust revenue growth of 38.66%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of BHST increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of BHST in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is BHST currently overvalued or undervalued?

What is Bioharvest Sciences Inc (BHST) fair value?

BHST's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Bioharvest Sciences Inc (BHST) is between 3.16 to 5.54 according to relative valuation method.

How does BHST's valuation metrics compare to the industry average?

The average P/S ratio for BHST's competitors is 0.64, providing a benchmark for relative valuation. Bioharvest Sciences Inc Corp (BHST) exhibits a P/S ratio of 2.76, which is 329.52% above the industry average. Given its robust revenue growth of 38.66%, this premium appears sustainable.

What is the current P/B ratio for Bioharvest Sciences Inc (BHST) as of Mar 03 2026?

As of Mar 03 2026, Bioharvest Sciences Inc (BHST) has a P/B ratio of 13.21. This indicates that the market values BHST at 13.21 times its book value.

What is the current FCF Yield for Bioharvest Sciences Inc (BHST) as of Mar 03 2026?

As of Mar 03 2026, Bioharvest Sciences Inc (BHST) has a FCF Yield of -8.01%. This means that for every dollar of Bioharvest Sciences Inc's market capitalization, the company generates -8.01 cents in free cash flow.

What is the current Forward P/E ratio for Bioharvest Sciences Inc (BHST) as of Mar 03 2026?

As of Mar 03 2026, Bioharvest Sciences Inc (BHST) has a Forward P/E ratio of -21.56. This means the market is willing to pay $-21.56 for every dollar of Bioharvest Sciences Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Bioharvest Sciences Inc (BHST) as of Mar 03 2026?

As of Mar 03 2026, Bioharvest Sciences Inc (BHST) has a Forward P/S ratio of 2.76. This means the market is valuing BHST at $2.76 for every dollar of expected revenue over the next 12 months.

BHST Valuation